Scarpellini E, Abenavoli L, Cassano V, Rinninella E, Sorge M, Capretti F, Rasetti C, Svegliati Baroni G, Luzza F, Santori P, Sciacqua A
Hepatology and Internal Medicine Unit, "Madonna del Soccorso" General Hospital, San Benedetto del Tronto, Italy.
T.A.R.G.I.D., Gasthuisberg University Hospital, KULeuven, Lueven, Belgium.
Front Med (Lausanne). 2022 Apr 26;9:872428. doi: 10.3389/fmed.2022.872428. eCollection 2022.
Gut microbiota are a complex ecosystem harboring our intestine. They maintain human body equilibrium, while their derangement, namely, "dysbiosis", has been associated with several gastrointestinal diseases, such as liver steatosis (NAFLD) and liver cirrhosis. Small intestinal bacterial overgrowth (SIBO) is an example of dysbiosis of the upper gastrointestinal (GI) tract.
The aim of this study is to evaluate the relationship between SIBO and levels of endotoxemia and grade of liver steatosis (LS) and liver fibrosis (LF) in hepatologic patients.
Consecutive outpatients referred to our hepatology clinic were tested for SIBO by the lactulose breath test (LBT) and peripheral blood levels of endotoxemia; LS grading and LF were assessed by abdominal ultrasound and transient elastography, respectively.
Fifty-two consecutive patients (17 with alcohol abuse (4.5 ± 0.8 alcohol units per day), 4 with HCV and 2 with HBV infection, 24 of metabolic origin, 2 of autoimmune origin, and 3 with cholangiopathies; mean age 54.7 ± 8.3 years, 31 F, BMI 24.1 ± 1.1 Kg/m) and 14 healthy volunteers (HV) (mean age 50.1 ± 4.3 years, 9 F, BMI 23.3 ± 1.1 Kg/m) were enrolled. SIBO prevalence was significantly higher in cirrhotic (LC) vs. non-cirrhotic (LNC) patients and vs. HV (all, < 0.05), with a significant positive trend according to Child-Pugh status (all, < 0.05). SIBO prevalence was not correlated with LS stages (all, = NS). Consensually, endotoxin levels were significantly higher in LC vs. LNC and vs. HV (all, < 0.05) and significantly correlated with LF in patients with LC, according to Child-Pugh status (all, < 0.05).
This study shows that SIBO prevalence and relative endotoxin blood levels seem to be significantly associated with the grade of LF vs. LS in LC. SIBO is also present under pre-cirrhotic conditions, but its prevalence seems to correlate with liver disease irreversible derangement.
肠道微生物群是存在于我们肠道中的一个复杂生态系统。它们维持着人体平衡,而其紊乱,即“生态失调”,与多种胃肠道疾病相关,如肝脂肪变性(非酒精性脂肪性肝病)和肝硬化。小肠细菌过度生长(SIBO)是上消化道(GI)生态失调的一个例子。
本研究旨在评估肝病患者中SIBO与内毒素血症水平、肝脂肪变性(LS)分级及肝纤维化(LF)分级之间的关系。
连续转诊至我们肝病门诊的门诊患者通过乳果糖呼气试验(LBT)检测SIBO,并检测外周血内毒素血症水平;分别通过腹部超声和瞬时弹性成像评估LS分级和LF。
连续纳入52例患者(17例有酒精滥用情况(每天饮酒4.5±0.8酒精单位),4例丙型肝炎病毒(HCV)感染,2例乙型肝炎病毒(HBV)感染,24例代谢性病因,2例自身免疫性病因,3例胆管疾病;平均年龄54.7±8.3岁,女性31例,体重指数(BMI)24.1±1.1kg/m²)和14名健康志愿者(HV)(平均年龄50.1±4.3岁,女性9例,BMI 23.3±1.1kg/m²)。肝硬化(LC)患者与非肝硬化(LNC)患者及HV相比,SIBO患病率显著更高(均P<0.05),根据Child-Pugh分级呈显著正相关趋势(均P<0.05)。SIBO患病率与LS分期无关(均P=NS)。一致的是,LC患者与LNC患者及HV相比,内毒素水平显著更高(均P<0.05),且根据Child-Pugh分级,LC患者的内毒素水平与LF显著相关(均P<0.05)。
本研究表明,SIBO患病率和相对内毒素血水平似乎与LC患者的LF分级而非LS分级显著相关。SIBO在肝硬化前期也存在,但其患病率似乎与肝病的不可逆紊乱相关。